how are you using pd-1 testing in melanoma?
Published 6 years ago • 810 plays • Length 7:38Download video MP4
Download video MP3
Similar videos
-
7:24
molecular testing in melanoma: braf and pd-l1
-
4:40
validity of pd-l1 testing in melanoma
-
5:37
pd-1 inhibitor use in melanoma
-
2:46
recommendations for molecular testing in melanoma
-
9:35
molecular testing in resectable melanoma
-
6:42
pseudoprogression with checkpoint inhibitors in non-small cell lung cancer
-
5:47
pd-l1 testing in metastatic nsclc
-
8:01
anti–pd-1 adjuvant therapy in melanoma
-
1:30
molecular testing in stage 3 melanoma
-
4:29
anti–pd-1 therapy in metastatic melanoma
-
10:20
pd-l1 testing in advanced lung cancer
-
4:47
pd-l1 biomarker testing
-
8:10
novel therapies in metastatic melanoma
-
10:54
immunotherapy in melanoma
-
8:04
treatment sequencing in braf metastatic melanoma
-
9:07
optimal treatment of metastatic melanoma at progression
-
13:55
mechanisms of pd1 resistance in melanoma and the combinatorial approach to therapies | adib daud, md
-
8:04
using i/o in msi-h tumors in mcrc
-
1:18
dr. joel neal on impact of pd-l1 tests on pembrolizumab, nivolumab efficacy in frontline nsclc